Ozempic is one of the few things giving CSL (ASX:CSL) shareholders sleepless nights right now. And you could argue this weight-loss drug is also having an impact on all biotech stocks. Because if you get rid of obesity, you might get rid of a lot of health problems that other biotech and medtech stocks are dealing…